

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.87093294 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58548289 |
| 3 | N-acetylneuraminate metabolic process (GO:0006054) | 4.53418766 |
| 4 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.41038984 |
| 5 | neutrophil mediated immunity (GO:0002446) | 4.40524525 |
| 6 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.29627489 |
| 7 | DNA deamination (GO:0045006) | 4.17414979 |
| 8 | amino sugar catabolic process (GO:0046348) | 4.02406833 |
| 9 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.95831597 |
| 10 | regulation of chemokine biosynthetic process (GO:0045073) | 3.79617883 |
| 11 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.79398063 |
| 12 | centriole replication (GO:0007099) | 3.71814634 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65993601 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.65993601 |
| 15 | interferon-gamma production (GO:0032609) | 3.62432235 |
| 16 | base-excision repair, AP site formation (GO:0006285) | 3.58083707 |
| 17 | positive regulation of histone deacetylation (GO:0031065) | 3.52483070 |
| 18 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.45268257 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45150891 |
| 20 | myeloid leukocyte mediated immunity (GO:0002444) | 3.44794036 |
| 21 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.37940142 |
| 22 | platelet dense granule organization (GO:0060155) | 3.35235307 |
| 23 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.35188792 |
| 24 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.33330404 |
| 25 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.32170126 |
| 26 | regulation of growth of symbiont in host (GO:0044126) | 3.32170126 |
| 27 | negative regulation of growth of symbiont in host (GO:0044130) | 3.32170126 |
| 28 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.32170126 |
| 29 | response to peptidoglycan (GO:0032494) | 3.28557822 |
| 30 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.23482341 |
| 31 | leukocyte aggregation (GO:0070486) | 3.17975248 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.17166058 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16945801 |
| 34 | neural tube formation (GO:0001841) | 3.14105678 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.13406527 |
| 36 | cytidine deamination (GO:0009972) | 3.11906160 |
| 37 | cytidine metabolic process (GO:0046087) | 3.11906160 |
| 38 | cytidine catabolic process (GO:0006216) | 3.11906160 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.11047404 |
| 40 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.06449505 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05778720 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.05778720 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05778720 |
| 44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05778720 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05778720 |
| 46 | modulation by symbiont of host immune response (GO:0052553) | 3.05778720 |
| 47 | positive regulation of protein deacetylation (GO:0090312) | 3.05518037 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.01410540 |
| 49 | cellular response to interleukin-15 (GO:0071350) | 2.98629565 |
| 50 | response to muramyl dipeptide (GO:0032495) | 2.98402510 |
| 51 | microglial cell activation (GO:0001774) | 2.94061407 |
| 52 | macrophage activation (GO:0042116) | 2.93949129 |
| 53 | reactive oxygen species biosynthetic process (GO:1903409) | 2.93514279 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 2.93292512 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 2.92053436 |
| 56 | macrophage chemotaxis (GO:0048246) | 2.91306396 |
| 57 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.88372864 |
| 58 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.84819690 |
| 59 | energy homeostasis (GO:0097009) | 2.84765131 |
| 60 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.84208380 |
| 61 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.84208380 |
| 62 | superoxide anion generation (GO:0042554) | 2.83942031 |
| 63 | positive regulation of prostaglandin secretion (GO:0032308) | 2.82854208 |
| 64 | protein deneddylation (GO:0000338) | 2.78938484 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.77250863 |
| 66 | heme biosynthetic process (GO:0006783) | 2.75580726 |
| 67 | negative regulation of interleukin-2 production (GO:0032703) | 2.75222620 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75056806 |
| 69 | defense response to fungus (GO:0050832) | 2.74501982 |
| 70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.72463463 |
| 71 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.71923762 |
| 72 | regulation of necroptotic process (GO:0060544) | 2.70139507 |
| 73 | T cell migration (GO:0072678) | 2.69892239 |
| 74 | cellular extravasation (GO:0045123) | 2.68784716 |
| 75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.65162642 |
| 76 | negative regulation of phagocytosis (GO:0050765) | 2.65004631 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 2.63945545 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.63445823 |
| 79 | cytokinetic process (GO:0032506) | 2.63079105 |
| 80 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.62641727 |
| 81 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.62605422 |
| 82 | N-acetylglucosamine metabolic process (GO:0006044) | 2.62331587 |
| 83 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61648712 |
| 84 | response to fungus (GO:0009620) | 2.60713823 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 2.60432338 |
| 86 | positive regulation of macrophage differentiation (GO:0045651) | 2.60227121 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 2.59399274 |
| 88 | centriole assembly (GO:0098534) | 2.58013624 |
| 89 | definitive hemopoiesis (GO:0060216) | 2.57903894 |
| 90 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.57575410 |
| 91 | ribosomal small subunit assembly (GO:0000028) | 2.56991870 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56231111 |
| 93 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56231111 |
| 94 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.55479205 |
| 95 | alpha-beta T cell differentiation (GO:0046632) | 2.54449171 |
| 96 | regulation of interleukin-8 secretion (GO:2000482) | 2.52907295 |
| 97 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.52153840 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.51851470 |
| 99 | regulation of interferon-alpha production (GO:0032647) | 2.51675458 |
| 100 | detection of other organism (GO:0098543) | 2.51307109 |
| 101 | neutrophil activation (GO:0042119) | 2.50911413 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.50629107 |
| 103 | cellular response to zinc ion (GO:0071294) | 2.49620993 |
| 104 | defense response to protozoan (GO:0042832) | 2.49481127 |
| 105 | leukocyte degranulation (GO:0043299) | 2.49453110 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.49166024 |
| 107 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48884674 |
| 108 | response to host immune response (GO:0052572) | 2.48884674 |
| 109 | positive regulation of B cell differentiation (GO:0045579) | 2.48628597 |
| 110 | response to type I interferon (GO:0034340) | 2.47814746 |
| 111 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.47727067 |
| 112 | cellular response to type I interferon (GO:0071357) | 2.47481652 |
| 113 | type I interferon signaling pathway (GO:0060337) | 2.47481652 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47262955 |
| 115 | positive regulation of DNA recombination (GO:0045911) | 2.47225775 |
| 116 | alpha-beta T cell activation (GO:0046631) | 2.46656684 |
| 117 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46336937 |
| 118 | response to interleukin-15 (GO:0070672) | 2.46008037 |
| 119 | negative regulation of granulocyte differentiation (GO:0030853) | 2.45923057 |
| 120 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45255190 |
| 121 | intracellular pH reduction (GO:0051452) | 2.45032251 |
| 122 | granulocyte activation (GO:0036230) | 2.44933562 |
| 123 | lymphocyte chemotaxis (GO:0048247) | 2.44508959 |
| 124 | response to protozoan (GO:0001562) | 2.43734849 |
| 125 | regulation of prostaglandin secretion (GO:0032306) | 2.43715214 |
| 126 | regulation of chronic inflammatory response (GO:0002676) | 2.43005003 |
| 127 | germinal center formation (GO:0002467) | 2.42869475 |
| 128 | hepatocyte apoptotic process (GO:0097284) | 2.42623136 |
| 129 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.41992876 |
| 130 | positive regulation of interleukin-1 production (GO:0032732) | 2.40592969 |
| 131 | tolerance induction (GO:0002507) | 2.39192958 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.38731138 |
| 133 | natural killer cell activation involved in immune response (GO:0002323) | 2.38613444 |
| 134 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.37044540 |
| 135 | signal peptide processing (GO:0006465) | 2.36357061 |
| 136 | positive regulation of mast cell activation (GO:0033005) | 2.35790747 |
| 137 | T-helper 1 type immune response (GO:0042088) | 2.35481894 |
| 138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35144613 |
| 139 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34420161 |
| 140 | response to host (GO:0075136) | 2.34420161 |
| 141 | response to host defenses (GO:0052200) | 2.34420161 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.34313045 |
| 143 | sequestering of actin monomers (GO:0042989) | 2.32244377 |
| 144 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.31812333 |
| 145 | positive regulation of mast cell degranulation (GO:0043306) | 2.31071708 |
| 146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.31071708 |
| 147 | B cell mediated immunity (GO:0019724) | 2.30800911 |
| 148 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.29741833 |
| 149 | myeloid dendritic cell activation (GO:0001773) | 2.29727043 |
| 150 | regulation of mast cell degranulation (GO:0043304) | 2.29006429 |
| 151 | regulation of B cell differentiation (GO:0045577) | 2.28752309 |
| 152 | myeloid cell activation involved in immune response (GO:0002275) | 2.28076879 |
| 153 | positive regulation of isotype switching (GO:0045830) | 2.26603198 |
| 154 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.26435326 |
| 155 | negative regulation of viral genome replication (GO:0045071) | 2.24190989 |
| 156 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.23988417 |
| 157 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.23287707 |
| 158 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.22931590 |
| 159 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.22672259 |
| 160 | mature B cell differentiation (GO:0002335) | 2.21950001 |
| 161 | regulation of RIG-I signaling pathway (GO:0039535) | 2.21939695 |
| 162 | natural killer cell mediated immunity (GO:0002228) | 2.21724716 |
| 163 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.21724716 |
| 164 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.21363187 |
| 165 | positive regulation of B cell mediated immunity (GO:0002714) | 2.20744979 |
| 166 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.20744979 |
| 167 | negative regulation of mast cell activation (GO:0033004) | 2.20544224 |
| 168 | dendritic cell migration (GO:0036336) | 2.20186467 |
| 169 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.20054211 |
| 170 | negative regulation of necroptotic process (GO:0060546) | 2.19266119 |
| 171 | respiratory burst (GO:0045730) | 2.18957918 |
| 172 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.18615538 |
| 173 | dendritic cell chemotaxis (GO:0002407) | 2.17759691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32750151 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.99821288 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.78700556 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.75269969 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72485034 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.45207235 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.26530617 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15713259 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.12049182 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.10973597 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10837526 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02846797 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.87740343 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.80949597 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68423323 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65571452 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59280691 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.55472332 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42594299 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.37029238 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.35014651 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.32051295 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.30981322 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.23670036 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22222496 |
| 26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20440646 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18790398 |
| 28 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06689156 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02989821 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99765937 |
| 31 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.98852650 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98516375 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98108764 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.94525581 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.81141083 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77088084 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73624639 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.70509702 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67561066 |
| 40 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62453199 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61940293 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60311229 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58816150 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52654079 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52579902 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51293868 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49883142 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49685342 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49065200 |
| 50 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.45566986 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45157291 |
| 52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43202973 |
| 53 | * MAF_26560356_Chip-Seq_TH1_Human | 1.41040725 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40186892 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39610226 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39523049 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37601198 |
| 58 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37477504 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36034785 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34804651 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32553016 |
| 62 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30307508 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30126868 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28435800 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27732917 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27384263 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26803425 |
| 68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26029259 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24541429 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24436413 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23564502 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22226030 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20855473 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18306744 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16409272 |
| 76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15617084 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15219205 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14818177 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13827066 |
| 80 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13680218 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12434324 |
| 82 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11933892 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11350568 |
| 84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11280521 |
| 85 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.11133366 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10461946 |
| 87 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09992097 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08005562 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07834310 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07584618 |
| 91 | GATA3_26560356_Chip-Seq_TH1_Human | 1.07097479 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07062464 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06882683 |
| 94 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06499390 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06021710 |
| 96 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05830694 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05418992 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04516339 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03800525 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03492185 |
| 101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02551990 |
| 102 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02409284 |
| 103 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01654087 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01008379 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00836009 |
| 106 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00343843 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99994189 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99994189 |
| 109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99086177 |
| 110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99086177 |
| 111 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98291638 |
| 112 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97540827 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96942888 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96320645 |
| 115 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.95388281 |
| 116 | MYC_22102868_ChIP-Seq_BL_Human | 0.94586297 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93911745 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92921446 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91726090 |
| 120 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.91721712 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91138581 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91127724 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91127724 |
| 124 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89633145 |
| 125 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89592075 |
| 126 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89456768 |
| 127 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89424617 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89133842 |
| 129 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88718245 |
| 130 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.88381326 |
| 131 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87838550 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86632461 |
| 133 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85604883 |
| 134 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.85507338 |
| 135 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.85430603 |
| 136 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82024537 |
| 137 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81521123 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80559483 |
| 139 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77926076 |
| 140 | MAF_26560356_Chip-Seq_TH2_Human | 0.77707370 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77577237 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77575058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 4.09343140 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.50803251 |
| 3 | MP0003724_increased_susceptibility_to | 3.37445267 |
| 4 | MP0009785_altered_susceptibility_to | 2.85325966 |
| 5 | MP0005671_abnormal_response_to | 2.76266951 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.62032205 |
| 7 | MP0003436_decreased_susceptibility_to | 2.51853142 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.44669211 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.30258613 |
| 10 | MP0005025_abnormal_response_to | 2.20721727 |
| 11 | MP0000685_abnormal_immune_system | 2.20377396 |
| 12 | MP0001800_abnormal_humoral_immune | 2.19808819 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.18916638 |
| 14 | MP0002419_abnormal_innate_immunity | 2.10477738 |
| 15 | MP0002723_abnormal_immune_serum | 2.06363103 |
| 16 | MP0002009_preneoplasia | 2.05964684 |
| 17 | MP0005387_immune_system_phenotype | 2.05028110 |
| 18 | MP0001790_abnormal_immune_system | 2.05028110 |
| 19 | MP0003828_pulmonary_edema | 2.04714745 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.01890293 |
| 21 | MP0001819_abnormal_immune_cell | 2.01709832 |
| 22 | MP0002132_abnormal_respiratory_system | 1.99920985 |
| 23 | MP0002405_respiratory_system_inflammati | 1.98569105 |
| 24 | MP0008961_abnormal_basal_metabolism | 1.98239083 |
| 25 | MP0003303_peritoneal_inflammation | 1.97183561 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.90621146 |
| 27 | MP0006082_CNS_inflammation | 1.85396821 |
| 28 | MP0003252_abnormal_bile_duct | 1.83818552 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.83226443 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.81078634 |
| 31 | MP0005365_abnormal_bile_salt | 1.76868088 |
| 32 | MP0002006_tumorigenesis | 1.70917286 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.67687534 |
| 34 | MP0003941_abnormal_skin_development | 1.66995256 |
| 35 | MP0002398_abnormal_bone_marrow | 1.64348416 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.62997678 |
| 37 | MP0003195_calcinosis | 1.61277971 |
| 38 | MP0000716_abnormal_immune_system | 1.54117132 |
| 39 | MP0001853_heart_inflammation | 1.52761927 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.51675957 |
| 41 | MP0005451_abnormal_body_composition | 1.49669008 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.48839092 |
| 43 | MP0000858_altered_metastatic_potential | 1.47314545 |
| 44 | MP0004947_skin_inflammation | 1.46743878 |
| 45 | MP0004043_abnormal_pH_regulation | 1.44312040 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.43709700 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.42380429 |
| 48 | MP0000490_abnormal_crypts_of | 1.41503345 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.40837963 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.38429881 |
| 51 | MP0005310_abnormal_salivary_gland | 1.38222676 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.37374358 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.37310530 |
| 54 | MP0009764_decreased_sensitivity_to | 1.36882432 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.34783374 |
| 56 | MP0001873_stomach_inflammation | 1.34213054 |
| 57 | MP0002722_abnormal_immune_system | 1.33990370 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.32351581 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.32263590 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.30062666 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.29235367 |
| 62 | MP0001879_abnormal_lymphatic_vessel | 1.28341951 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.27882508 |
| 64 | MP0002429_abnormal_blood_cell | 1.26731336 |
| 65 | MP0001542_abnormal_bone_strength | 1.26018504 |
| 66 | MP0005670_abnormal_white_adipose | 1.22367348 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.20106379 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.19002104 |
| 69 | MP0001851_eye_inflammation | 1.18859272 |
| 70 | MP0004381_abnormal_hair_follicle | 1.18249943 |
| 71 | MP0004510_myositis | 1.16640318 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.16100760 |
| 73 | MP0003448_altered_tumor_morphology | 1.15817638 |
| 74 | MP0008057_abnormal_DNA_replication | 1.12926624 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.11154742 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.11154742 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.10407081 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.09696598 |
| 79 | MP0009379_abnormal_foot_pigmentation | 1.09064105 |
| 80 | MP0009763_increased_sensitivity_to | 1.06015076 |
| 81 | MP0000343_altered_response_to | 1.05709389 |
| 82 | MP0002254_reproductive_system_inflammat | 1.04514087 |
| 83 | MP0005390_skeleton_phenotype | 1.03751086 |
| 84 | MP0002928_abnormal_bile_duct | 1.01818563 |
| 85 | MP0002095_abnormal_skin_pigmentation | 1.01625726 |
| 86 | MP0002933_joint_inflammation | 1.00367548 |
| 87 | MP0008469_abnormal_protein_level | 0.99610941 |
| 88 | MP0000516_abnormal_urinary_system | 0.99609478 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 0.99609478 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.98910629 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.98351034 |
| 92 | MP0008872_abnormal_physiological_respon | 0.98053744 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.97784171 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.97625292 |
| 95 | MP0003866_abnormal_defecation | 0.95755842 |
| 96 | MP0009278_abnormal_bone_marrow | 0.94998213 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.93683924 |
| 98 | MP0008004_abnormal_stomach_pH | 0.93324165 |
| 99 | MP0003693_abnormal_embryo_hatching | 0.92624862 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.89864946 |
| 101 | MP0006292_abnormal_olfactory_placode | 0.88676056 |
| 102 | MP0004142_abnormal_muscle_tone | 0.87191134 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.84973157 |
| 104 | MP0006054_spinal_hemorrhage | 0.84686993 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.83416385 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.82943219 |
| 107 | MP0008058_abnormal_DNA_repair | 0.82640570 |
| 108 | MP0003136_yellow_coat_color | 0.82042955 |
| 109 | MP0000249_abnormal_blood_vessel | 0.81221577 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.80747787 |
| 111 | MP0010094_abnormal_chromosome_stability | 0.80435016 |
| 112 | MP0005253_abnormal_eye_physiology | 0.78875552 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.77896883 |
| 114 | MP0003075_altered_response_to | 0.77096059 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.77069316 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.76933623 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.74121597 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.73470878 |
| 119 | MP0000049_abnormal_middle_ear | 0.73453327 |
| 120 | MP0005248_abnormal_Harderian_gland | 0.73272793 |
| 121 | MP0003077_abnormal_cell_cycle | 0.72905502 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.72407737 |
| 123 | MP0005166_decreased_susceptibility_to | 0.71417960 |
| 124 | MP0002019_abnormal_tumor_incidence | 0.71348349 |
| 125 | MP0003111_abnormal_nucleus_morphology | 0.70779401 |
| 126 | MP0003795_abnormal_bone_structure | 0.70086730 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.69349231 |
| 128 | MP0008877_abnormal_DNA_methylation | 0.68870547 |
| 129 | MP0001119_abnormal_female_reproductive | 0.68784779 |
| 130 | MP0001191_abnormal_skin_condition | 0.68221639 |
| 131 | MP0002177_abnormal_outer_ear | 0.67703189 |
| 132 | MP0001188_hyperpigmentation | 0.67313707 |
| 133 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67162372 |
| 134 | MP0008873_increased_physiological_sensi | 0.66341836 |
| 135 | MP0009115_abnormal_fat_cell | 0.65595756 |
| 136 | MP0005164_abnormal_response_to | 0.64089506 |
| 137 | MP0009053_abnormal_anal_canal | 0.63047112 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.62615634 |
| 139 | MP0003786_premature_aging | 0.62393871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.50220948 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.33462280 |
| 3 | Myositis (HP:0100614) | 4.01783772 |
| 4 | Prostate neoplasm (HP:0100787) | 3.98605402 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.67118604 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 3.59986142 |
| 7 | Orchitis (HP:0100796) | 3.51479170 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.48674319 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.30865905 |
| 10 | Optic neuritis (HP:0100653) | 3.30865905 |
| 11 | Obstructive lung disease (HP:0006536) | 3.18351767 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18351767 |
| 13 | IgM deficiency (HP:0002850) | 3.17014521 |
| 14 | Abnormality of the prostate (HP:0008775) | 3.10750286 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.00951688 |
| 16 | Stomatitis (HP:0010280) | 3.00870046 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99230918 |
| 18 | Meningitis (HP:0001287) | 2.94883179 |
| 19 | Recurrent fungal infections (HP:0002841) | 2.93763281 |
| 20 | Increased IgM level (HP:0003496) | 2.90427947 |
| 21 | Chest pain (HP:0100749) | 2.78412118 |
| 22 | Episodic fever (HP:0001954) | 2.75337166 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70230125 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70230125 |
| 25 | Cheilitis (HP:0100825) | 2.68718250 |
| 26 | Recurrent bronchitis (HP:0002837) | 2.67927258 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 2.65922842 |
| 28 | Vasculitis (HP:0002633) | 2.61965691 |
| 29 | Prolonged bleeding time (HP:0003010) | 2.56839271 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 2.53210485 |
| 31 | Granulocytopenia (HP:0001913) | 2.52139144 |
| 32 | Exertional dyspnea (HP:0002875) | 2.50807615 |
| 33 | Recurrent skin infections (HP:0001581) | 2.49577307 |
| 34 | Pulmonary infiltrates (HP:0002113) | 2.46139301 |
| 35 | Hypoproteinemia (HP:0003075) | 2.45330056 |
| 36 | Gingivitis (HP:0000230) | 2.39951117 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39633596 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39633596 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39633596 |
| 40 | Recurrent viral infections (HP:0004429) | 2.37585150 |
| 41 | Chronic diarrhea (HP:0002028) | 2.37267094 |
| 42 | Pulmonary fibrosis (HP:0002206) | 2.37221492 |
| 43 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37072289 |
| 44 | Abnormality of the nasal septum (HP:0000419) | 2.34233357 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.33132012 |
| 46 | Spinal cord lesions (HP:0100561) | 2.32833679 |
| 47 | Syringomyelia (HP:0003396) | 2.32833679 |
| 48 | Parakeratosis (HP:0001036) | 2.30778584 |
| 49 | IgG deficiency (HP:0004315) | 2.30245694 |
| 50 | Porencephaly (HP:0002132) | 2.28535989 |
| 51 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.27827087 |
| 52 | Pustule (HP:0200039) | 2.26490230 |
| 53 | Arterial thrombosis (HP:0004420) | 2.25565911 |
| 54 | Abnormality of T cells (HP:0002843) | 2.25435204 |
| 55 | Medial flaring of the eyebrow (HP:0010747) | 2.23763994 |
| 56 | Leukocytosis (HP:0001974) | 2.19292024 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.19291775 |
| 58 | Hemoptysis (HP:0002105) | 2.17777294 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.17602835 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.17565609 |
| 61 | Reticulocytopenia (HP:0001896) | 2.17148336 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 2.17144712 |
| 63 | Keratoconjunctivitis (HP:0001096) | 2.14880053 |
| 64 | Pulmonary embolism (HP:0002204) | 2.14681407 |
| 65 | Increased muscle lipid content (HP:0009058) | 2.14670455 |
| 66 | Hematochezia (HP:0002573) | 2.14479792 |
| 67 | Agammaglobulinemia (HP:0004432) | 2.12948395 |
| 68 | Chromsome breakage (HP:0040012) | 2.12234556 |
| 69 | Thyroiditis (HP:0100646) | 2.11197229 |
| 70 | Aplastic anemia (HP:0001915) | 2.08793712 |
| 71 | Epistaxis (HP:0000421) | 2.08621531 |
| 72 | Periodontitis (HP:0000704) | 2.07910122 |
| 73 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07578877 |
| 74 | Urticaria (HP:0001025) | 2.06373061 |
| 75 | Glomerulopathy (HP:0100820) | 2.06153565 |
| 76 | Reduced antithrombin III activity (HP:0001976) | 2.05798041 |
| 77 | Polyneuropathy (HP:0001271) | 2.03399588 |
| 78 | Lymphopenia (HP:0001888) | 2.02587280 |
| 79 | Constricted visual fields (HP:0001133) | 2.02338114 |
| 80 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.02000709 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.01996903 |
| 82 | Cutaneous photosensitivity (HP:0000992) | 2.01860955 |
| 83 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01104346 |
| 84 | Recurrent sinusitis (HP:0011108) | 1.97999241 |
| 85 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97460149 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.97399373 |
| 87 | Abnormality of the pericardium (HP:0001697) | 1.97188394 |
| 88 | Impaired platelet aggregation (HP:0003540) | 1.96403895 |
| 89 | Abnormal platelet function (HP:0011869) | 1.96403895 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96351856 |
| 91 | Mitochondrial inheritance (HP:0001427) | 1.96107969 |
| 92 | Abnormality of eosinophils (HP:0001879) | 1.95806615 |
| 93 | Adactyly (HP:0009776) | 1.95469390 |
| 94 | Cellulitis (HP:0100658) | 1.94995383 |
| 95 | Gangrene (HP:0100758) | 1.94772365 |
| 96 | Abnormality of the renal cortex (HP:0011035) | 1.94276259 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94244531 |
| 98 | Petechiae (HP:0000967) | 1.92675973 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91583894 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.90989580 |
| 101 | Chronic sinusitis (HP:0011109) | 1.90868179 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 1.90068202 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 1.89158936 |
| 104 | Attenuation of retinal blood vessels (HP:0007843) | 1.88717215 |
| 105 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.87548652 |
| 106 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87487469 |
| 107 | Bronchitis (HP:0012387) | 1.86474024 |
| 108 | Pancreatitis (HP:0001733) | 1.85642437 |
| 109 | Acute myeloid leukemia (HP:0004808) | 1.85622309 |
| 110 | IgA deficiency (HP:0002720) | 1.85484398 |
| 111 | Encephalitis (HP:0002383) | 1.84447988 |
| 112 | Recurrent pneumonia (HP:0006532) | 1.84165448 |
| 113 | Autoimmune hemolytic anemia (HP:0001890) | 1.83096833 |
| 114 | Keratitis (HP:0000491) | 1.82968107 |
| 115 | Abnormality of male internal genitalia (HP:0000022) | 1.82633673 |
| 116 | Abnormality of T cell number (HP:0011839) | 1.82323375 |
| 117 | Albinism (HP:0001022) | 1.82277147 |
| 118 | Combined immunodeficiency (HP:0005387) | 1.82267528 |
| 119 | Lymphoma (HP:0002665) | 1.80028778 |
| 120 | Lip pit (HP:0100267) | 1.79625993 |
| 121 | Pulmonary artery stenosis (HP:0004415) | 1.79033206 |
| 122 | Congenital, generalized hypertrichosis (HP:0004540) | 1.78938622 |
| 123 | T lymphocytopenia (HP:0005403) | 1.78501211 |
| 124 | Nasal polyposis (HP:0100582) | 1.77917192 |
| 125 | Failure to thrive in infancy (HP:0001531) | 1.77482739 |
| 126 | Intestinal atresia (HP:0011100) | 1.75960555 |
| 127 | Eosinophilia (HP:0001880) | 1.75243309 |
| 128 | Clubbing of toes (HP:0100760) | 1.74827180 |
| 129 | Severe combined immunodeficiency (HP:0004430) | 1.74725971 |
| 130 | Molar tooth sign on MRI (HP:0002419) | 1.73964531 |
| 131 | Abnormality of midbrain morphology (HP:0002418) | 1.73964531 |
| 132 | Metaphyseal dysplasia (HP:0100255) | 1.73872724 |
| 133 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73440436 |
| 134 | Recurrent lower respiratory tract infections (HP:0002783) | 1.73328726 |
| 135 | Congenital primary aphakia (HP:0007707) | 1.72876690 |
| 136 | Neoplasm of the adrenal cortex (HP:0100641) | 1.72162495 |
| 137 | Gastrointestinal stroma tumor (HP:0100723) | 1.72004513 |
| 138 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.71891240 |
| 139 | Hypoplasia of the fovea (HP:0007750) | 1.71891240 |
| 140 | Hypothermia (HP:0002045) | 1.71419060 |
| 141 | Gastrointestinal inflammation (HP:0004386) | 1.71371376 |
| 142 | Osteomyelitis (HP:0002754) | 1.71156868 |
| 143 | Spontaneous hematomas (HP:0007420) | 1.70852002 |
| 144 | Gingival bleeding (HP:0000225) | 1.67608027 |
| 145 | Basal ganglia calcification (HP:0002135) | 1.66809875 |
| 146 | Anorexia (HP:0002039) | 1.66629566 |
| 147 | Abnormality of the pleura (HP:0002103) | 1.65628585 |
| 148 | Bronchiectasis (HP:0002110) | 1.65039037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CCNB1 | 4.78415461 |
| 2 | TXK | 3.51777957 |
| 3 | MAP3K14 | 3.18907137 |
| 4 | CAMKK2 | 3.16722361 |
| 5 | NEK2 | 2.90457228 |
| 6 | TESK2 | 2.90373785 |
| 7 | ZAK | 2.41348009 |
| 8 | VRK2 | 2.39218911 |
| 9 | IRAK4 | 2.35876339 |
| 10 | TEC | 2.35850425 |
| 11 | IKBKE | 2.22005187 |
| 12 | BLK | 2.19769783 |
| 13 | JAK3 | 2.05544053 |
| 14 | TBK1 | 2.04195074 |
| 15 | NME2 | 2.01492035 |
| 16 | IKBKB | 2.00155328 |
| 17 | EPHA3 | 1.86261150 |
| 18 | MAP4K1 | 1.84571899 |
| 19 | KIT | 1.83998712 |
| 20 | NEK9 | 1.83366852 |
| 21 | MST1R | 1.81428002 |
| 22 | EIF2AK3 | 1.78332837 |
| 23 | PIM2 | 1.77092800 |
| 24 | NLK | 1.74655320 |
| 25 | CASK | 1.68982109 |
| 26 | MAP4K2 | 1.65412262 |
| 27 | DYRK3 | 1.63767489 |
| 28 | BMPR1B | 1.60226116 |
| 29 | TYK2 | 1.56873700 |
| 30 | GRK6 | 1.53096244 |
| 31 | YES1 | 1.51388394 |
| 32 | IRAK3 | 1.51062364 |
| 33 | PIM1 | 1.48701269 |
| 34 | CDK8 | 1.47028045 |
| 35 | ZAP70 | 1.46464110 |
| 36 | CHUK | 1.46196851 |
| 37 | MKNK2 | 1.45893067 |
| 38 | TGFBR1 | 1.45883796 |
| 39 | EIF2AK2 | 1.42943358 |
| 40 | RIPK4 | 1.42725090 |
| 41 | BTK | 1.37691634 |
| 42 | TGFBR2 | 1.31084871 |
| 43 | FRK | 1.25695016 |
| 44 | TAOK3 | 1.24735756 |
| 45 | MAP3K11 | 1.23791307 |
| 46 | MST4 | 1.22998181 |
| 47 | TAF1 | 1.21966368 |
| 48 | STK24 | 1.18806483 |
| 49 | ACVR1B | 1.17979905 |
| 50 | RPS6KA4 | 1.15944939 |
| 51 | CSK | 1.15901754 |
| 52 | CAMK1D | 1.15293540 |
| 53 | TNK2 | 1.14619839 |
| 54 | LIMK1 | 1.12595004 |
| 55 | PIK3CG | 1.09432804 |
| 56 | SRPK1 | 1.09058327 |
| 57 | PTK2B | 1.05017820 |
| 58 | MARK3 | 1.03627901 |
| 59 | GRK5 | 1.03253143 |
| 60 | BMPR2 | 1.02230151 |
| 61 | LYN | 1.01764769 |
| 62 | ERN1 | 1.01698343 |
| 63 | MAPK15 | 1.01111760 |
| 64 | SIK3 | 1.00731479 |
| 65 | VRK1 | 1.00655854 |
| 66 | CLK1 | 0.99976527 |
| 67 | MKNK1 | 0.99887736 |
| 68 | MATK | 0.99295049 |
| 69 | CSNK1G3 | 0.97857685 |
| 70 | LCK | 0.97217863 |
| 71 | SYK | 0.95977643 |
| 72 | IRAK1 | 0.93227165 |
| 73 | EPHB1 | 0.93183275 |
| 74 | CDK9 | 0.92219272 |
| 75 | CSNK1A1L | 0.90232499 |
| 76 | JAK1 | 0.90189008 |
| 77 | CDK3 | 0.89264660 |
| 78 | ITK | 0.86630419 |
| 79 | PDK2 | 0.84415172 |
| 80 | TAOK2 | 0.83775313 |
| 81 | CDK7 | 0.83502274 |
| 82 | GRK1 | 0.82989889 |
| 83 | CSNK1G1 | 0.80339992 |
| 84 | CDK12 | 0.78462972 |
| 85 | STK10 | 0.76241209 |
| 86 | PBK | 0.76196982 |
| 87 | LRRK2 | 0.75861892 |
| 88 | FGR | 0.74763651 |
| 89 | ERBB3 | 0.74126562 |
| 90 | KDR | 0.74036579 |
| 91 | DAPK1 | 0.73037786 |
| 92 | FLT3 | 0.72528736 |
| 93 | STK4 | 0.71098382 |
| 94 | FGFR3 | 0.68158836 |
| 95 | TRPM7 | 0.67560252 |
| 96 | MAP2K3 | 0.66131845 |
| 97 | BCKDK | 0.64459369 |
| 98 | MAP3K7 | 0.63246120 |
| 99 | ABL2 | 0.62924821 |
| 100 | MAP3K13 | 0.61553965 |
| 101 | ADRBK1 | 0.61373201 |
| 102 | FES | 0.60760317 |
| 103 | ADRBK2 | 0.60692856 |
| 104 | RPS6KA5 | 0.60556932 |
| 105 | CSNK1G2 | 0.60380735 |
| 106 | IRAK2 | 0.60232492 |
| 107 | MAP3K12 | 0.59639718 |
| 108 | MAP3K1 | 0.59031554 |
| 109 | CSF1R | 0.58579054 |
| 110 | HCK | 0.58179564 |
| 111 | GRK7 | 0.57881315 |
| 112 | PIK3CA | 0.57258618 |
| 113 | TLK1 | 0.56582436 |
| 114 | ATR | 0.55875089 |
| 115 | NUAK1 | 0.54616277 |
| 116 | MOS | 0.54263145 |
| 117 | HIPK2 | 0.53632653 |
| 118 | TRIM28 | 0.53063906 |
| 119 | MAP3K5 | 0.52675814 |
| 120 | STK3 | 0.50366401 |
| 121 | JAK2 | 0.48440621 |
| 122 | PRKCQ | 0.47241029 |
| 123 | MAPK11 | 0.47120361 |
| 124 | TIE1 | 0.46929237 |
| 125 | MUSK | 0.46862137 |
| 126 | INSRR | 0.46770423 |
| 127 | TESK1 | 0.43694094 |
| 128 | TNIK | 0.43448694 |
| 129 | WNK3 | 0.42821434 |
| 130 | CAMK1G | 0.42020059 |
| 131 | MAP2K2 | 0.41783230 |
| 132 | MAP3K3 | 0.40429495 |
| 133 | BCR | 0.39346222 |
| 134 | ABL1 | 0.38844092 |
| 135 | RPS6KA6 | 0.38696758 |
| 136 | AURKB | 0.37800485 |
| 137 | PLK2 | 0.36708565 |
| 138 | MAPKAPK2 | 0.35819357 |
| 139 | PRKD2 | 0.35688511 |
| 140 | TAOK1 | 0.35153315 |
| 141 | DYRK1B | 0.35092234 |
| 142 | MAP3K10 | 0.34130750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43309454 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.33040411 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16992852 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13596955 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.11110110 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05720223 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.98954509 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.97919074 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91916572 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87770627 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83820596 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.81982509 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79591544 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.78437118 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.70052736 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66515875 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66270569 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.63221677 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62585241 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58723783 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.56078315 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48292056 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46749895 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.46688355 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46053635 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44157288 |
| 27 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.43459216 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43089022 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40523538 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.34542832 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.33491341 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33298675 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33030492 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.32784401 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32758083 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31817455 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28138423 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.27855569 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.26463171 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.25310436 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.24435623 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.23631064 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21837228 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19832754 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17416573 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.16454603 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15222457 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14902867 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.14322062 |
| 50 | Proteasome_Homo sapiens_hsa03050 | 1.13274239 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12566410 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11716308 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09057669 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07776769 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.06728498 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06585182 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05751782 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05113033 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.04939982 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02324886 |
| 61 | DNA replication_Homo sapiens_hsa03030 | 1.02018731 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.99777496 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99776847 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99223362 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89889413 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.89411526 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88546510 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88169218 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87988327 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87817847 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87712432 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.87334897 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87157704 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84348239 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84219159 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.83756093 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.83413171 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.82907465 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82298568 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.80875299 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80707681 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79721462 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79666484 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78037825 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77602197 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77503465 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76502678 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.76109742 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75941555 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75259614 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74423801 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.72904867 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71942101 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71628700 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69163672 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68665108 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64747867 |
| 98 | RNA polymerase_Homo sapiens_hsa03020 | 0.63046061 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62358161 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59181435 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.58290198 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57826759 |
| 103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56617931 |
| 104 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55311826 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.54929622 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54691647 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54518008 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53832217 |
| 109 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53299700 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53280294 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52774017 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52444073 |
| 113 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52093611 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50475720 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50152802 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.47727550 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47176623 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46928520 |
| 119 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.46644798 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46019904 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45423833 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.45107912 |
| 123 | Mismatch repair_Homo sapiens_hsa03430 | 0.44883024 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43483972 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41751522 |
| 126 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40575830 |
| 127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40091071 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39604011 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.39171185 |
| 130 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39037612 |
| 131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35937774 |
| 132 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34399447 |

